Search

Author/Creator Eldfors, Samuli

1. Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells. Issue 6 (4th November 2018)

Authors:
Saeed, Khalid; Ojamies, Poojitha; Pellinen, Teijo; Eldfors, Samuli; Turkki, Riku; Lundin, Johan; Järvinen, Petrus; Nisen, Harry; Taari, Kimmo; af Hällström, Taija M.; Rannikko, Antti; Mirtti, Tuomas; Kallioniemi, Olli; Östling, Päivi
Journal:
International journal of cancer
Issue:
Volume 144:Issue 6(2019)
Page Start:
1356
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Epidemiological, clinical and molecular characterization of Lynch‐like syndrome: A population‐based study. Issue 1 (7th January 2019)

Authors:
Porkka, Noora; Lahtinen, Laura; Ahtiainen, Maarit; Böhm, Jan P.; Kuopio, Teijo; Eldfors, Samuli; Mecklin, Jukka‐Pekka; Seppälä, Toni T.; Peltomäki, Päivi
Journal:
International journal of cancer
Issue:
Volume 145:Issue 1(2019)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer. Issue 1 (December 2016)

Authors:
Kangaspeska, Sara; Hultsch, Susanne; Jaiswal, Alok; Edgren, Henrik; Mpindi, John-Patrick; Eldfors, Samuli; Brück, Oscar; Aittokallio, Tero; Kallioniemi, Olli
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗